Edition:
International

Business & Financial News, U.S & International Breaking News

Vials of Johnson & Johnson's Janssen coronavirus disease (COVID-19) vaccine...

U.S. authorizes Johnson & Johnson's COVID-19 vaccine

Approval of the single-dose vaccine will enable millions more Americans to get shots in coming weeks and will set it up for additional approvals. Few serious side effects were reported in a global trial, which also suggested that the vaccine reduced asymptomatic infections.

THE WIRE

More Top News

Advertisement

Have a news tip?

Reuters provides several ways to securely and confidentially share information and materials with our journalists.

LEARN MORE ››

Signup for our newsletter

Subscribe to our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.